<DOC>
	<DOCNO>NCT01861236</DOCNO>
	<brief_summary>Prospective , observational study collect analyze data patient advance hormone dependent prostate cancer treat Firmagon® accord routine medical practice Argentina</brief_summary>
	<brief_title>Effectiveness Safety Firmagon® Androgen Ablative Therapy Advanced Hormone-dependent Prostate Carcinoma Argentina</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>Advanced Prostate Cancer patient treat Firmagon context usual clinical practice Written inform consent Contraindications Firmagon Patients already Firmagon therapy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>